AAAAAA

   
Results: 1-13 |
Results: 13
Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes
Authors: West, AB Zimprich, A Lockhart, PJ Farrer, M Singleton, A Holtom, B Lincoln, S Hofer, A Hill, L Muller-Myhsok, B Wszolek, ZK Hardy, J Gasser, T
Citation: Ab. West et al., Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes, EUR J HUM G, 9(9), 2001, pp. 659-666
Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter
Authors: Matsuoka, Y Vila, M Lincoln, S McCormack, A Picciano, M LaFrancois, J Yu, X Dickson, D Langston, WJ McGowan, E Farrer, M Hardy, J Duff, K Przedborski, S Di Monte, DA
Citation: Y. Matsuoka et al., Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter, NEUROBIOL D, 8(3), 2001, pp. 535-539
Lewy bodies and parkinsonism in families with parkin mutations
Authors: Farrer, M Chan, P Chen, R Tan, L Lincoln, S Hernandez, D Forno, L Gwinn-Hardy, K Petrucelli, L Hussey, J Singleton, A Tanner, C Hardy, J Langston, JW
Citation: M. Farrer et al., Lewy bodies and parkinsonism in families with parkin mutations, ANN NEUROL, 50(3), 2001, pp. 293-300
Pathology of PD in monozygotic twins with a 20-year discordance interval
Authors: Dickson, D Farrer, M Lincoln, S Mason, RP Zimmerman, TR Golbe, LI Hardy, J
Citation: D. Dickson et al., Pathology of PD in monozygotic twins with a 20-year discordance interval, NEUROLOGY, 56(7), 2001, pp. 981-982
Linkage exclusion in French families with probable Parkinson's disease
Authors: Farrer, M Destee, T Becquet, E Wavrant-De Vrieze, F Mouroux, V Richard, F Defebvre, L Lincoln, S Hardy, J Amouyel, S Chartier-Harlin, MC
Citation: M. Farrer et al., Linkage exclusion in French families with probable Parkinson's disease, MOVEMENT D, 15(6), 2000, pp. 1075-1083
A kindred with Parkinson's disease not showing genetic linkage to established loci
Authors: Gwinn-Hardy, KA Crook, R Lincoln, S Adler, CH Caviness, JN Hardy, J Farrer, M
Citation: Ka. Gwinn-hardy et al., A kindred with Parkinson's disease not showing genetic linkage to established loci, NEUROLOGY, 54(2), 2000, pp. 504-507
Alzheimer disease PS-1 exon 9 deletion defined
Authors: Prihar, G Verkkoniemi, A Perez-Tur, J Crook, R Lincoln, S Moulden, H Somer, M Paetau, A Kalimo, H Grover, A Myllykangas, L Hutton, M Hardy, J Haltia, M
Citation: G. Prihar et al., Alzheimer disease PS-1 exon 9 deletion defined, NAT MED, 5(10), 1999, pp. 1090-1090
A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor
Authors: Farrer, M Gwinn-Hardy, K Muenter, M DeVrieze, FW Crook, R Perez-Tur, J Lincoln, S Maraganore, D Adler, C Newman, S MacElwee, K McCarthy, P Miller, C Waters, C Hardy, J
Citation: M. Farrer et al., A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor, HUM MOL GEN, 8(1), 1999, pp. 81-85
Low frequency of pathogenic mutations in the ubiquitin carboxyterminal hydrolase gene in familial Parkinson's disease
Authors: Lincoln, S Vaughan, J Wood, N Baker, M Adamson, J Gwinn-Hardy, K Lynch, T Hardy, J Farrer, M
Citation: S. Lincoln et al., Low frequency of pathogenic mutations in the ubiquitin carboxyterminal hydrolase gene in familial Parkinson's disease, NEUROREPORT, 10(2), 1999, pp. 427-429
The lle93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease
Authors: Harhangi, BS Farrer, MJ Lincoln, S Bonifati, V Meco, G De Michele, G Brice, A Durr, A Martinez, M Gasser, T Bereznai, B Vaughan, JR Wood, NW Hardy, J Oostra, BA Breteler, MMB
Citation: Bs. Harhangi et al., The lle93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease, NEUROSCI L, 270(1), 1999, pp. 1-4
No pathogenic mutations in the beta-synuclein gene in Parkinson's disease
Authors: Lincoln, S Crook, R Chartier-Harlin, MC Gwinn-Hardy, K Baker, M Mouroux, V Richard, F Becquet, E Amouyel, P Destee, A Hardy, J Farrer, M
Citation: S. Lincoln et al., No pathogenic mutations in the beta-synuclein gene in Parkinson's disease, NEUROSCI L, 269(2), 1999, pp. 107-109
No pathogenic mutations in the persyn gene in Parkinson's disease
Authors: Lincoln, S Gwinn-Hardy, K Goudreau, J Chartier-Harlin, MC Baker, M Mouroux, V Richard, F Destee, A Becquet, E Amouyel, P Lynch, T Hardy, J Farrer, M
Citation: S. Lincoln et al., No pathogenic mutations in the persyn gene in Parkinson's disease, NEUROSCI L, 259(1), 1999, pp. 65-66
A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling
Authors: Steiner, H Duff, K Capell, A Romig, H Grim, MG Lincoln, S Hardy, J Yu, X Picciano, M Fechteler, K Citron, M Kopan, R Pesold, B Keck, S Baader, M Tomita, T Iwatsubo, T Baumeister, R Haass, C
Citation: H. Steiner et al., A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling, J BIOL CHEM, 274(40), 1999, pp. 28669-28673
Risultati: 1-13 |